Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neoplasms
Interventions: DRUG: AZD2171|DRUG: AZD0530
Sponsor: AstraZeneca